经皮冠脉介入治疗老年冠心病心绞痛的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of percutaneous coronary intervention (PCI) in the elderly patients with coronary heart disease and angina pectoris. Methods A total of 80 elderly patients with coronary heart disease and angina pectoris admitted to Haimen People′s Hospital from January 2016 to December 2018 were selected as the research objects, they were divided into the conservative treatment group (40 cases) and the PCI group (40 cases) according to the random number table method and voluntary principles. The conservative treatment group received conventional drug therapy, and the PCI group received PCI treatment, followed up for 12 months. The total effectiveness of treatment, Seattle angina questionnaire (SAQ) score, cardiac adverse events (recurrent angina pectoris, myocardial infarction, cardiogenic death) were compared between the two groups. Results The total effective rate of PCI group was 97.50%, higher than that of conservative group (85.00%), the difference was statistically significant (P<0.05). The SAQ scores of PCI group (angina attack, angina stable state, limited physical activity, subjective feeling and treatment plan satisfaction) were all higher than those of the conservative group, the differences were statistically significant (P<0.05).There was no significant difference in the incidence of cardiac adverse events between the two groups (P＞0.05). Conclusion PCI has a significant clinical effect on angina pectoris in elderly patients with coronary heart disease, which can improve the quality of life of elderly patients with coronary heart disease and angina pectoris, and is worthy of clinical application.

Key words： Percutaneous coronary intervention Elderly Coronary heart disease Angina Clinical efficacy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SHI Sheng-feng

Cite this article:

SHI Sheng-feng. Clinical effect of percutaneous coronary intervention in the treatment of angina pectoris in elderly patients with coronary heart disease[J]. 中国当代医药, 2021, 28(3): 95-97.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I3/95

[1]	罗孝成.冠脉介入治疗高龄冠心病心绞痛的临床分析[J].基层医学论坛，2019，23（7）：59-60.
[2]	王雪丹.倍他乐克治疗老年冠心病心绞痛的临床疗效[J].当代医学，2020，26（3）：16-18.
[3]	李五记.经桡动脉冠状动脉造影后即行支架植入应用于老年冠心病心绞痛的效果[J].现代临床医学，2020，46（1）：13-14.
[4]	杭亮，田慧娟.自拟丹蒌合剂治疗冠心病心绞痛患者100 例[J].环球中医药，2019，12（3）：60-64.
[5]	张玉梅，李劲松.经皮冠状动脉介入治疗老年冠心病心绞痛患者的疗效分析[J].血管与腔内血管外科杂志，2019，5（4）：346-349.
[6]	Golukhova EZ，Grigoryan MV，Ryabinina MN，et al.High on-treatment platelet reactivity determinants on dual antiplatelet therapy in patients with ischemic heart disease before elective percutaneous coronary intervention[J].Kardiologiia，2018，58（4）：5-14.
[7]	Lu Y，Zhang H，Wang Y，et al.Percutaneous coronary intervention in patients without acute myocardial infarction in china：results from the china peace prospective study of percutaneous coronary intervention[J].JAMA Netw Open，2018，1（8）：e185446.
[8]	中华医学会心血管病学分会，中华心血管病杂志编辑委员会.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志，2007，35（3）：195-206.
[9]	朱国栋.冠脉介入治疗高龄冠心病心绞痛的临床效果及有效率影响分析[J].世界复合医学，2019，5（10）：118-121.
[10]	解光辉，李运正.探析老年冠心病冠状动脉搭桥术后再发心绞痛介入治疗的效果[J].中国医药指南，2016，14（32）：99.
[11]	Waheed N，Mahmoud A，Rambarat CA，et al.Advances in small-molecule therapy for managing angina pectoris in the elderly[J].Expert Opin Pharmacother，2019，20（12）：1471-1481.
[12]	蔡芮桐，尹文浩，张泽等.中医特色疗法在老年冠心病心绞痛中应用研究进展[J].辽宁中医药大学学报，2020，22（4）：96-99.
[14]	鲁爱粉，王恒亮，白广海，等.冠状动脉介入治疗高龄冠心病心绞痛患者的疗效评价[J].深圳中西医结合杂志，201，29（23）：23-24.
[15]	柯伟良，李上海，李日健，等.冠脉介入治疗高龄冠心病心绞痛的临床分析[J].中外医学研究，2019，17（28）：149-151.
[16]	高伟华.冠状动脉介入治疗老年冠心病心绞痛患者的临床效果[J].深圳中西医结合杂志，2019，29（23）：136-137.
[13]	Wang K，Wu J，Duan X，et al.Comparative efficacy of Chinese herbal injections for angina pectoris：A Bayesian network meta-analysis of randomized controlled trials[J].Complement Ther Med，2019，43（2）：208-217.